Recently, I was asked to comment on a new potential blood test for breast cancer risk. This test is different from the one I noted in a recent blog http://drwinsett.blogspot.com/2012/04/detecting-breast-cancer-in-blood-test.html.
This new finding (http://apps.facebook.com/theguardian/science/2012/apr/30/blood-test-breast-cancer-risk?post_gdp=true) may help detect breast cancer risk. The research, lead by Dr. James Flanagan, found that the ATM gene was more likely to show the epigenetic change of methylation (see my blog for more about how the environment can change our genes http://drwinsett.blogspot.com/2012/03/and-you-thought-you-couldnt-change-your.html) in patients who subsequently developed breast cancer. Those with the highest methylation level on the ATM gene found in white blood cells were twice as likely to get breast cancer. We don't know what environmental factors cause the change in the white blood cell gene or why it is associated with more breast cancers. Their hope is that with the confirmation of the finding from this simple blood test we can then find those at high risk and offer "pre-emptive" strategies.
At present the most accurate breast cancer risk assessment tool is the BREVAGen test, a cheek swab with clinical data about you. For more information read http://drwinsett.blogspot.com/2011/09/easier-way-to-learn-your-risk.html and call 512-451-5788 or email www.thedoctor@owenwinsettmd.com to come get one.
Together we can prevent 75,000 breast cancer cases each year!
At present the most accurate breast cancer risk assessment tool is the BREVAGen test, a cheek swab with clinical data about you. For more information read http://drwinsett.blogspot.com/2011/09/easier-way-to-learn-your-risk.html and call 512-451-5788 or email www.thedoctor@owenwinsettmd.com to come get one.
Together we can prevent 75,000 breast cancer cases each year!
No comments:
Post a Comment